Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OST-122 by Oncostellae for Ulcerative Colitis: Likelihood of Approval
OST-122 is under clinical development by Oncostellae and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II...